Personal Cfo Solutions, LLC Cerus Corp Transaction History

Personal Cfo Solutions, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$4.41 - $5.69 $15,435 - $19,915	-3,500 Reduced 17.95%	16,000 $85,000
Q1 2022 May 02, 2022	SELL	$4.81 - $6.99 $33,670 - $48,930	-7,000 Reduced 26.42%	19,500 $107,000
Q4 2021 Feb 11, 2022	SELL	$5.97 - $7.93 $8,955 - $11,895	-1,500 Reduced 5.36%	26,500 $180,000
Q3 2021 Nov 18, 2021	SELL	$4.79 - $6.68 $28,500 - $39,746	-5,950 Reduced 17.53%	28,000 $171,000
Q2 2021 Jul 22, 2021	SELL	$5.35 - $6.35 $10,700 - $12,700	-2,000 Reduced 5.56%	33,950 $201,000
Q1 2021 Apr 21, 2021	SELL	$5.68 - $7.87 $33,443 - $46,338	-5,888 Reduced 14.07%	35,950 $216,000
Q4 2020 Feb 09, 2021	BUY	$5.25 - $8.56 $79,737 - $130,009	15,188 Added 56.99%	41,838 $289,000
Q2 2020 Aug 03, 2020	SELL	$4.5 - $7.02 $51,696 - $80,645	-11,488 Reduced 30.12%	26,650 $176,000
Q1 2020 Apr 30, 2020	BUY	$2.87 - $5.49 $109,456 - $209,377	38,138 New	38,138 $177,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Personal Cfo Solutions, LLC with notifications on news.